Related Experiment Video
Updated: Aug 12, 2026
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Variable phenotypes in a family kindred with adrenoleukodystrophy
1Department of Pediatrics, Texas Tech University Health Sciences Center, Lubbock 79430.
Pediatric Neurology
|January 1, 1991
Summary
This case report details the earliest known onset of X-linked adrenoleukodystrophy in a 20-month-old boy. Early diagnosis is crucial for managing this severe neurological disorder.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- X-linked adrenoleukodystrophy (X-ALD) is a severe genetic disorder causing progressive demyelination and adrenal insufficiency.
- Typically, X-ALD manifests in childhood (4-8 years) with neurological and adrenal symptoms.
Observation:
- A 20-month-old male presented with acute neurological decline, including status epilepticus and cortical blindness, followed by temporary recovery.
- Relapse occurred 3 months later, with MRI revealing severe white matter disease, indicating advanced X-ALD.
- This represents the earliest documented onset of X-linked adrenoleukodystrophy.
Findings:
- Elevated C26 long-chain saturated fatty acid levels confirmed the diagnosis of X-ALD.
- Genetic analysis of family members identified affected individuals, highlighting the X-linked inheritance pattern.
Implications:
- This case underscores the possibility of earlier-than-usual onset for X-linked adrenoleukodystrophy.
- Early detection through biochemical markers is vital for timely intervention and management of X-ALD.
- Further research into the early pathogenesis of X-ALD may improve diagnostic and therapeutic strategies.
Related Concept Videos
01:11Genetic Lingo
Overview
01:35Pedigree Analysis
Overview
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:43Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...